Daptomycin and Doxycycline hyclate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Daptomycin (daptomycin) and Doxycycline hyclate (doxycycline hyclate). Common drug interactions include pyrexia among females and staphylococcal infection among males.

The phase IV clinical study analyzes what interactions people have when they take Daptomycin and Doxycycline hyclate. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Doxycycline hyclate?

Doxycycline hyclate has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 17,884 Doxycycline hyclate users. Check the latest studies of Doxycycline hyclate.



On Aug, 12, 2026

39 people who take Daptomycin and Doxycycline hyclate together, and have interactions are studied.

Daptomycin and Doxycycline hyclate drug interactions.

What are the common drug interactions of Daptomycin and Doxycycline Hyclate, by gender? *:

female:

  1. Pyrexia (fever)
  2. Back pain
  3. Blood creatinine increased
  4. Intervertebral discitis (infection in the intervertebral disc space)
  5. Nausea (feeling of having an urge to vomit)
  6. Osteonecrosis (death of bone)
  7. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Asymptomatic bacteriuria (the presence of bacteria in urine not due to contamination from urine sample collection)
  10. Atrophy (wasting away of a part of the body)

male:

  1. Staphylococcal infection (an infection with staphylococcus bacteria)
  2. General physical health deterioration (weak health status)
  3. Gamma-glutamyltransferase increased
  4. Insomnia (sleeplessness)
  5. Interstitial lung disease
  6. Muscle spasms (muscle contraction)
  7. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  8. Osteomyelitis (infection of bone)
  9. Renal failure (kidney dysfunction)
  10. Skin ulcer

What are the common drug interactions of Daptomycin and Doxycycline Hyclate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug hypersensitivity
  2. Nausea (feeling of having an urge to vomit)
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Pyrexia (fever)
  5. Skin lesion
  6. Drug ineffective
  7. Blood creatine phosphokinase increased
  8. Erythema (redness of the skin)
  9. Pain of skin
  10. Abscess (pus)

30-39:

  1. Drug ineffective
  2. Drug resistance (reduction in effectiveness of a drug)

40-49:

  1. Back pain
  2. Blood creatinine increased
  3. Intervertebral discitis (infection in the intervertebral disc space)
  4. Osteonecrosis (death of bone)
  5. Arteriosclerosis (thickening and hardening of arteries)
  6. Asymptomatic bacteriuria (the presence of bacteria in urine not due to contamination from urine sample collection)
  7. Atrophy (wasting away of a part of the body)
  8. Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  9. Inflammatory marker increased
  10. Pyrexia (fever)

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Gamma-glutamyltransferase increased
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue)
  6. Osteomyelitis (infection of bone)
  7. Skin ulcer

60+:

  1. Small intestinal obstruction (blockage in small intestine)
  2. Acute generalised exanthematous pustulosis (acute febrile drug eruption)
  3. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  4. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  6. Cauda equina syndrome (affecting the bundle of nerve roots)
  7. Drug hypersensitivity
  8. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  9. Eosinophilic pneumonia (eosinophil accumulates in the lung)
  10. Interstitial lung disease

What are the existing conditions these people have? *

  1. Staphylococcal Infection (an infection with staphylococcus bacteria): 15 people, 38.46%
  2. Pain: 14 people, 35.90%
  3. Osteomyelitis (infection of bone): 4 people, 10.26%
  4. Pneumonia: 3 people, 7.69%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.69%
  6. Paraspinal Abscess: 3 people, 7.69%
  7. Intervertebral Discitis (infection in the intervertebral disc space): 3 people, 7.69%
  8. Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 7.69%
  9. Burkholderia Cepacia Complex Infection (complex infection by group of bacteria burkholderia cepacia -resistant to common antibiotics): 3 people, 7.69%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and Doxycycline hyclate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Daptomycin and Doxycycline hyclate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Doxycycline hyclate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxycycline hyclate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on daptomycin and doxycycline hyclate (the active ingredients of Daptomycin and Doxycycline hyclate, respectively), and Daptomycin and Doxycycline hyclate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: